COVID‐19‐associated pulmonary aspergillosis (CAPA): Risk factors and development of a predictive score for critically ill COVID‐19 patients

J Calderón‐Parra, P Mills‐Sanchez… - Mycoses, 2022 - Wiley Online Library
Background COVID‐19‐associated pulmonary aspergillosis (CAPA) is a major complication
of critically ill COVID‐19 patients, with a high mortality rate and potentially preventable …

[PDF][PDF] Invasive fungal infections in patients with COVID-19: A review on pathogenesis, epidemiology, clinical features, treatment, and outcomes

M Chiurlo, A Mastrangelo, M Ripa… - New …, 2021 - newmicrobiologica.org
SUMMARY COVID-19 is frequently associated with the onset of secondary infections,
especially in severe cases treated in the intensive care unit. While bacterial pathogens are …

Fungal pathogens and COVID-19

A Singh, A Kaur, A Chowdhary - Current Opinion in Microbiology, 2023 - Elsevier
COVID-19 pandemic highlighted the complications of secondary fungal infections that
occurred globally in severe cases of coronavirus disease managed in the intensive care …

[HTML][HTML] The Menace of Candida auris Epidemic Amidst the COVID-19 Pandemic: A Systematic Review

H Najeeb, SA Siddiqui, Z Anas, SH Ali, SUR Usmani… - Diseases, 2022 - mdpi.com
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), the causative agent for
the Coronavirus Disease 2019 (COVID-19) pandemic, has sparked a medical emergency …

[HTML][HTML] Overview of COVID-19-associated invasive fungal infection

AA Shishido, M Mathew, JW Baddley - Current Fungal Infection Reports, 2022 - Springer
Abstract Purpose of Review Invasive fungal infections are a complication of COVID-19
disease. This article reviews literature characterizing invasive fungal infections associated …

[HTML][HTML] The complexity of co-infections in the era of COVID-19

N Cimolai - SN Comprehensive Clinical Medicine, 2021 - Springer
The current frequency of COVID-19 in a pandemic era ensures that co-infections with a
variety of co-pathogens will occur. Generally, there is a low rate of bonafide co-infections in …

[HTML][HTML] Co-infections and superinfections complicating COVID-19 in cancer patients: a multicentre, international study

C Gudiol, X Durà-Miralles, J Aguilar-Company… - Journal of Infection, 2021 - Elsevier
Background We aimed to describe the epidemiology, risk factors, and clinical outcomes of
co-infections and superinfections in onco-hematological patients with COVID-19. Methods …

[HTML][HTML] Bioactive metabolites of Streptomyces misakiensis display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi

R Abdelaziz, YH Tartor, AB Barakat… - Frontiers in Cellular …, 2023 - frontiersin.org
Background Antimicrobial resistance is a serious threat to public health globally. It is a
slower-moving pandemic than COVID-19, so we are fast running out of treatment options …

[HTML][HTML] Epidemiology of systemic mycoses in the COVID-19 pandemic

MG Frias-De-Leon, R Pinto-Almazan… - Journal of Fungi, 2021 - mdpi.com
The physiopathologic characteristics of COVID-19 (high levels of inflammatory cytokines and
T-cell reduction) promote fungal colonization and infection, which can go unnoticed because …

[HTML][HTML] COVID-19 associated mold infections: Review of COVID-19 associated pulmonary aspergillosis and mucormycosis

SF Huang, AYJ Wu, SSJ Lee, YS Huang… - Journal of Microbiology …, 2023 - Elsevier
Abstract COVID-19-associated mold infection (CAMI) is defined as development of mold
infections in COVID-19 patients. Co-pathogenesis of viral and fungal infections include the …